ClinConnect ClinConnect Logo
Search / Trial NCT06517992

Collaborative cOMMUNIty Care for Metastatic breAsT cancEr Patients in inDonesia (Communicated)

Launched by GADJAH MADA UNIVERSITY · Jul 20, 2024

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

Cadre Education Community Empowerment Indonesia Metastatic Breast Cancer

ClinConnect Summary

The "Collaborative cOMMUNIty Care for Metastatic Breast Cancer Patients in Indonesia" trial is designed to improve support and care for patients with metastatic breast cancer, which means the cancer has spread beyond the breast to other parts of the body. This study will empower local community members, known as "cadres," in Bali and Yogyakarta to provide better care for these patients. The trial is not yet recruiting participants, but it aims to include adults aged 18 and older who have been diagnosed with stage 3B or higher breast cancer and are living at home. It will also involve family members who care for these patients and local cadres willing to help.

Participants can expect to receive support from trained community members who understand the challenges of living with metastatic breast cancer. The study focuses on enhancing the care environment and ensuring that patients and their caregivers have access to the assistance they need. It’s important to note that patients who are very ill or need to be hospitalized will not be included in this study. This trial hopes to make a significant difference in the lives of those affected by metastatic breast cancer in these communities.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria for mBC:
  • Diagnosed for having breast cancer at least in stage 3B or confirm to have metastatic breast cancer
  • Live at home
  • Considered as adult (Eighteen years of age or older)
  • Exclusion Criteria for mBC:
  • - mBC patients will be exclude when their physical condition is deteriorating or when they need hospitalization.
  • The following criteria will be applied for family caregivers:
  • 1. Appointed by mBC patients or self-identified as family caregiver of mBC patients for at least 3 months
  • 2. Live/not live together with mBC patients but providing care to mBC patient
  • 3. Considered as adult (Eighteen years of age or older)
  • Inclusion criteria for cadre:
  • The local cadre in Yogyakarta and Bali who self-identified as local cadre in the community and willing to involve for assisting mBC patients. The local cadre will be excluded when they are not providing consent to involve in the current study.

About Gadjah Mada University

Gadjah Mada University, a prestigious institution located in Yogyakarta, Indonesia, is recognized for its commitment to advancing research and innovation in various fields, including health sciences. As a clinical trial sponsor, the university leverages its extensive academic expertise and state-of-the-art facilities to conduct rigorous clinical research aimed at enhancing medical knowledge and improving patient outcomes. With a focus on ethical standards and scientific integrity, Gadjah Mada University collaborates with healthcare professionals and researchers to ensure that its clinical trials contribute valuable insights to the medical community and support the development of effective treatments.

Locations

Yogyakarta, Daerah Istimewa Yogyakarta, Indonesia

Bali, , Indonesia

Patients applied

0 patients applied

Trial Officials

Syahirul Alim, PhD

Study Chair

Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported